Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.

Lymphocytes, especially CD4+ T cells, are essential for clearance of the yeast-like organism Cryptococcus neoformans from the infected host. The mechanism(s) by which the lymphocytes facilitate elimination of cryptococci has not been elucidated. It is generally thought, however, that lymphocytes reactive with C. neoformans indirectly function by production of lymphokines to enhance clearance of the organism by natural effector cells such as macrophages. In the present study, we assessed the ability of freshly isolated human lymphocytes to interact directly with C. neoformans and to limit the growth of the organism in vitro. We found that large granular lymphocytes (LGL) as well as T cells bound to cryptococcal cells when the lymphocytes were mixed with the cryptococcal cells at a 2:1 ratio. The physical binding interactions of the two lymphocyte populations were different. LGL attached to the cryptococcal cells by many microvilli; T lymphocytes associated with the yeast through broad areas of membrane attached to the cryptococcal cell surface. The two types of lymphocyte interactions did not result in phagocytosis but resulted in direct inhibition of cryptococcal growth, making these lymphocyte interactions with cryptococci distinctly different from interactions of monocytes with cryptococci. With the human natural killer (NK) cell line, NK 3.3, we confirmed that NK cells that were present in the LGL population were capable of limiting the growth of C. neoformans. Through immunoelectron microscopy, human CD3+ lymphocytes were seen attached to cryptococcal cells and by mass cytolysis, human CD3+ lymphocytes were shown to be responsible for inhibition of C. neoformans growth. The direct inhibitory interactions of NK cells and T lymphocytes with cryptococcal cells may be important means of host defense against this ubiquitous organism that frequently causes life-threatening disease in AIDS patients.

[1]  J. O. Hill CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract , 1992, The Journal of experimental medicine.

[2]  J. Durbec,et al.  Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[3]  S. Levitz Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans , 1991, Infection and immunity.

[4]  C. Salkowski,et al.  Role of Natural Killer Cells in Resistance to Systemic Cryptococcosis , 1991, Journal of leukocyte biology.

[5]  R. Maziarz,et al.  Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. , 1991, The Journal of infectious diseases.

[6]  J. Murphy,et al.  Murine natural killer cells are fungicidal to Cryptococcus neoformans , 1991, Infection and immunity.

[7]  J. Murphy,et al.  Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans , 1991, Infection and immunity.

[8]  J. Murphy,et al.  Binding interactions of murine natural killer cells with the fungal target Cryptococcus neoformans , 1991, Infection and immunity.

[9]  G. Huffnagle,et al.  Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells , 1991, The Journal of experimental medicine.

[10]  A. Harmsen,et al.  Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells , 1991, The Journal of experimental medicine.

[11]  T. G. Mitchell,et al.  Killing of Cryptococcus neoformans strains by human neutrophils and monocytes , 1991, Infection and immunity.

[12]  Craig W. Reynolds,et al.  Cytoplasmic Components of Natural Killer Cells Limit the Growth of Cryptococcus neoformans , 1990, Journal of leukocyte biology.

[13]  S. Levitz,et al.  Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines , 1990, Infection and immunity.

[14]  T. G. Mitchell,et al.  Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody , 1990, Infection and immunity.

[15]  C. Mody,et al.  Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. , 1990, Journal of immunology.

[16]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[17]  F. Ognibene,et al.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. , 1989, Annals of internal medicine.

[18]  J. Murphy,et al.  Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans , 1989, Infection and immunity.

[19]  R. Habbersett,et al.  Resolving leukocytes using axial light loss. , 1989, Cytometry.

[20]  Juneann W. Murphy,et al.  Natural Host Resistance Mechanisms against Systemic Mycotic Agents , 1989 .

[21]  D. Armstrong,et al.  Life‐Threatening Opportunistic Fungal Infection in Patients with the Acquired Immunodeficiency Syndrome , 1988, Annals of the New York Academy of Sciences.

[22]  M. Frank,et al.  C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes. , 1988, Journal of immunology.

[23]  G. Toews,et al.  Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. , 1987, The American journal of pathology.

[24]  J. Murphy,et al.  Natural cellular resistance of beige mice against Cryptococcus neoformans. , 1986, Journal of immunology.

[25]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[26]  J. Murphy,et al.  Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells , 1986, Infection and immunity.

[27]  E. Gelmann,et al.  Cryptococcosis in the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[28]  J. Murphy,et al.  In vitro binding of natural killer cells to Cryptococcus neoformans targets , 1985, Infection and immunity.

[29]  C. Tuazon,et al.  Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome. , 1985, The Journal of infectious diseases.

[30]  J. Puck,et al.  In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects. , 1984, Journal of immunology.

[31]  B. Dupont,et al.  Cell surface phenotype of a cloned line of human natural killer cells. , 1982, Journal of immunology.

[32]  J. Murphy,et al.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans , 1982, Infection and immunity.

[33]  J. Kearney,et al.  A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. , 1982, Clinical immunology and immunopathology.

[34]  A. Forrestel,et al.  CRYPTOCOCCOSIS , 1982, The Lancet.

[35]  J. Murphy,et al.  In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. , 1982, Journal of immunology.

[36]  J. Ortaldo,et al.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells , 1981, The Journal of experimental medicine.

[37]  R. Hoffman,et al.  Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Murphy,et al.  Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice. , 1980, Infection and immunity.

[39]  J. Murphy,et al.  Response of Congenitally Athymic (Nude) and Phenotypically Normal Mice to Cryptococcus neoformans Infection , 1979, Infection and immunity.

[40]  A. Allison,et al.  Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans , 1976, Infection and immunity.

[41]  R. Diamond Antibody-dependent Killing of Cryptococcus neoformans by Human Peripheral Blood Mononuclear Cells , 1974, Nature.

[42]  J. Bennett,et al.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. , 1972, The Journal of infectious diseases.